Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles

Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles

Background: Lung cancer is one of the most common types of cancer, and it has a poor prognosis. It is urgent to identify prognostic biomarkers to guide therapy.Methods: The immune gene expression profiles for patients with lung adenocarcinomas (LUADs) were obtained from The Cancer Genome Atlas (TCGA...

Full description

Bibliographic Details
Main Authors: Bo Ling, Guangbin Ye, Qiuhua Zhao, Yan Jiang, Lingling Liang, Qianli Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Molecular Biosciences
Subjects:
lung adenocarcinomas
immune checkpoint genes
immune subtypes
immune gene expression profile
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2020.603701/full

Similar Items

Similar Items